CD44‐stimulated dendrite formation (‘spreading’) in activated B cells
- 1 January 1997
- journal article
- Published by Wiley in Immunology
- Vol. 90 (1) , 147-153
- https://doi.org/10.1046/j.1365-2567.1997.00126.x
Abstract
A rat monoclonal antibody (mAb) (NIM-R8), insolubilized by binding to plastic plates, induced a rapid and extensive formation of dendrite processes ('spreading') in B lymphocytes activated by anti-IgM and interleukin-4 (IL-4) or anti-CD38 and IL-4. In contrast, resting B cells were unable to spread similarly on the NIM-R8-coated plates. The NIM-R8 antibody recognized a 90,000 MW surface glycoprotein (gp90) present on both B and T lymphocytes. The expression of this molecule was greatly increased after polyclonal (lipopolysaccharide, anti-IgM plus IL-4 or concanavalin A) activation. The NIM-R8 mAb with or without IL-2 or IL-4 was unable to induce proliferation of splenic lymphocytes. Following the demonstration that the NIM-R8 mAb recognizes the murine equivalent of human CD44, the induction of spreading of activated B lymphocytes was studied using a panel of mAb recognizing different epitopes of murine CD44. All of these different mAb induced similar spreading of activated B cells. The ligand-inducible spreading of activated B lymphocytes may be an important mechanism for providing an increased cell-surface area for cell-cell or cell-matrix interactions, and thus may be an important factor controlling the response of activated lymphocytes.Keywords
This publication has 26 references indexed in Scilit:
- ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons.The Journal of cell biology, 1994
- Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.The Journal of Experimental Medicine, 1994
- Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44.The Journal of Experimental Medicine, 1993
- Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition.The Journal of cell biology, 1992
- Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody.The Journal of Experimental Medicine, 1992
- Distinct effects of two CD44 isoforms on tumor growth in vivo.The Journal of Experimental Medicine, 1991
- T and B cell collaboration: induction of motility in small, resting B cells by interleukin 4European Journal of Immunology, 1991
- Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.The Journal of Experimental Medicine, 1990
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- Preparation and characterisation of an antiserum to the mouse candidate for immunoglobulin DNature, 1976